Related Experiment Video
Updated: Aug 7, 2026
09:38
Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery
Published on: April 14, 2016
Drug interactions with patient-controlled analgesia
Jorn Lotsch1, Carsten Skarke, Irmgard Tegeder
1Pharmazentrum Frankfurt, Klinikum der Johann Wolfgang Goethe-Universität, Frankfurt, Germany. j.loetsch@em.uni-frankfurt.de
Clinical Pharmacokinetics
|February 5, 2002
Summary
Patient-controlled analgesia (PCA) involves drug interactions that can be clinically significant. Understanding these interactions is crucial for safe and effective pain management, impacting drug metabolism, protein binding, and synergistic effects.
Area of Science:
- Pharmacology
- Clinical Pharmacy
- Pain Management
Background:
- Patient-controlled analgesia (PCA) is a standard pain management technique.
- Concomitant drug administration in PCA patients can lead to various drug interactions.
- Some drug interactions during PCA have significant clinical implications.
Purpose of the Study:
- To review the clinical significance of drug interactions in patient-controlled analgesia.
- To categorize drug interactions based on pharmacokinetic and pharmacodynamic effects.
- To highlight specific examples of clinically relevant drug interactions in PCA.
Main Methods:
- Literature review of reported drug interactions in patient-controlled analgesia.
- Analysis of pharmacokinetic interactions involving drug metabolism (CYP enzymes) and protein binding.
- Analysis of pharmacodynamic interactions, including synergistic and additive effects.
Main Results:
- Pharmacokinetic interactions can alter drug levels through altered metabolism (e.g., CYP3A4, CYP2D6) or protein binding.
- Pharmacodynamic interactions include synergistic effects of combined opioids and non-opioids, and additive analgesic effects.
- Inconsistent effects of antiemetics on opioid-induced nausea and sedation were noted.
Conclusions:
- Drug interactions in PCA can range from minor to serious, affecting drug efficacy and safety.
- Understanding pharmacokinetic and pharmacodynamic interactions is vital for optimizing PCA therapy.
- Further research is needed to clarify interactions, particularly regarding adverse effects like nausea and sedation.
Related Concept Videos
01:25Analgesia and Pain Management
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
01:20Opioid Analgesics: Morphine and Other Natural Cogeners
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
01:24Parenteral Anesthetics: Overview
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
01:25Pharmacokinetics: Drug–Drug Interactions
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
01:30Drug toxicity: Drug–Drug Interaction
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...